Florence Le Calvez-Kelm (Florence Le Calvez-Klem)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Venues

International journal of molecular sciences

Biomedicines

Cancers

Molecular biology reports

International Agency for Research on Cancer

University of Liege (ULg), Belgium (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

International Agency for Research on Cancer Jun 06 2006

France

Scientist :: Genetic Cancer Susceptibility

University of Leuven, Belgium

Belgium

Post-doctoral fellowship; Scientific Collaborator of EuroGentest project :: Laboratory for Molecular Diagnosis Center of Human Genetics

International Agency for Cancer Research, France. Feb 28 2002 - Mar 31 2005

France

Position as Molecular Biology Engineer, in parallel to PhD studies, :: Molecular Carcinogenesis

Education History

University of Liege (ULg), Belgium Jan 28 2002 - Apr 29 2005

Belgium

PHD

National Institute of Applied Sciences, Lyon, France

France

MSC :: Biochemistry

University of Caen, France

France

BSC :: Institute of Biochemistry and Applied Biology,

Publications

Thorsten H Ecke, Florence Le Calvez-Kelm, Thomas Otto
Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision. International journal of molecular sciences 23 (10) (2022)
Tsimur Hasanau, Eduard Pisarev, Olga V Kisil, Naosuke Nonoguchi, Florence Le Calvez-Kelm, Maria I Zvereva
Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances. Biomedicines 10 (3) (2022)
Hamid Pakmanesh, Omid Anvari, Nathalie Forey, Elisabete Weiderpass, Reza Malekpourafshar, Maryam Iranpour, Armita Shahesmaeili, Nahid Ahmadi, Azam Bazrafshan, Kazem Zendehdel, Caroline Kannengiesser, Ibrahima Ba, James McKay, Maria I Zvereva, Md Ismail Hosen, Mahdi Sheikh, Florence Le Calvez-Kelm
TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region. International journal of molecular sciences 23 (22) (2022)
Imen Hemissi, Sami Boussetta, Hamza Dallali, Faycel Hellal, Geoffroy Durand, Catherine Voegele, Haroun Ayed, Selim Zaghbib, Zeineb Naimi, Mouna Ayadi, Mohamed Chebil, James D McKay, Florence Le Calvez-Kelm, Slah Ouerhani
Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort. Molecular biology reports (2021)
Md Ismail Hosen, Nathalie Forey, Geoffroy Durand, Catherine Voegele, Selin Bilici, Patrice Hodonou Avogbe, Tiffany Myriam Delhomme, Matthieu Foll, Arnaud Manel, Emmanuel Vian, Sonia Meziani, Berengere De Tilly, Gilles Polo, Olesia Lole, Pauline Francois, Antoine Boureille, Eduard Pisarev, Andrei R O S E Salas, Sara Monteiro-Reis, Rui M Henrique, Graham Byrnes, Carmen Jerónimo, Ghislaine Scelo, James D McKay, Florence Le Calvez-Kelm, Maria I Zvereva
Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer. Cancers 12 (12) (2020)
Thorsten H Ecke, Thomas Otto, Florence Le Calvez-Kelm
Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision? International journal of molecular sciences 21 (24) (2020)

Florence Le Calvez-Kelm.css-eqlu8i{font-size:small;padding-left:4px;} (Florence Le Calvez-Klem)

Publication Activity (10 Years)

Top Topics

Top Venues

Florence Le Calvez-Kelm (Florence Le Calvez-Klem)